Prostate News Archive
03-Apr-2009
Prostate cancer worries women (Daily Telegraph)
WOMEN are initially more distressed by prostate cancer than their male partners who are diagnosed with the disease, a study has found. Prostate Cancer Conference at Mayo Clinic (KAAL Austin)
(KAAL) -- It's a type of cancer that some call the "couple disease". The Mayo Clinic in Rochester held a conference on prostate cancer, allowing men to gather information they and their loved ones may need in order to deal with the disease and life after. Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer ... (Business Wire via Yahoo! Finance)
CHICAGO----Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners." For Men, a Saving Surgery: Twenty-Five Years Ago, Patrick C. Walsh Devised a Prostate-Cancer Operation That Allowed ... (RedNova)
By Marie McCullough, The Philadelphia Inquirer Apr. 30--In 1982, the surgical cure for prostate cancer was considered worse than the disease. Removing the prostate meant life-threatening bleeding, guaranteed impotence, and a 1 in 4 chance of incontinence. GTX Shares Fall on Study Concern (AP via Yahoo! Finance)
Shares of biotechnology company GTX Inc. stumbled Monday on concerns on the risks involved with a late-stage study of the company's prostate cancer drug Acapodene.
Back to Prostate News Archive
